Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis to Brain of Primary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07132190
What this trial is testing

Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction

Who this might be right for
Brain Metastases, AdultBrain Tumor - MetastaticBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+1 more
Ayal A. Aizer, MD 60
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Testing effectiveness (Phase 2)Study completedNCT05865990
What this trial is testing

HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease

Who this might be right for
Metastatic Breast CancerAdvanced Non-Small Cell Squamous Lung CancerSolid Tumor, Adult
MedSIR 63
Not applicableLooking for participantsNCT06468124
What this trial is testing

Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases

Who this might be right for
Breast Neoplasms
King's College London 20
Testing effectiveness (Phase 2)Study completedNCT01898130
What this trial is testing

Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy

Who this might be right for
Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University 27
Testing effectiveness (Phase 2)Ended earlyNCT00977379
What this trial is testing

Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis

Who this might be right for
Breast Cancer
Hoffmann-La Roche 24
Early research (Phase 1)Study completedNCT04396717
What this trial is testing

Safety Study of Pritumumab in Brain Cancer

Who this might be right for
Malignant Primary Brain TumorsBrain Metastases, Adult
Nascent Biotech 15
Testing effectiveness (Phase 2)UnknownNCT04582968
What this trial is testing

Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases

Who this might be right for
Breast CancerBrain MetastasesHER2-positive Breast Cancer
Fudan University 39
Large-scale testing (Phase 3)Study completedNCT00377156
What this trial is testing

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Breast CancerCognitive/Functional EffectsLung Cancer+2 more
Alliance for Clinical Trials in Oncology 213
Not applicableActive Not RecruitingNCT00683319
What this trial is testing

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

Who this might be right for
Brain and Central Nervous System TumorsCognitive/Functional EffectsLong-term Effects Secondary to Cancer Therapy in Children+1 more
Children's Cancer and Leukaemia Group 50
Testing effectiveness (Phase 2)Looking for participantsNCT07535463
What this trial is testing

Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 53
Not applicableUnknownNCT06014450
What this trial is testing

Prophylactic Cranial Irradiation Versus Observation in Stage IV NSCLC Randomized Controlled Clinical Study

Who this might be right for
Prophylactic Cranial Irradiation, Cumulative Incidence of Brain Metastases
Guizhou Medical University 144
Testing effectiveness (Phase 2)Study completedNCT02308020
What this trial is testing

Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

Who this might be right for
Breast CancerNon-small Cell Lung CancerMelanoma+1 more
Eli Lilly and Company 162
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07365410
What this trial is testing

Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Brain MetastasesFurmonertinib+1 more
Tianjin Medical University Cancer Institute and Hospital 60
Early research (Phase 1)Study completedNCT02423525
What this trial is testing

Safety Study of Afatinib for Brain Cancer

Who this might be right for
Brain Cancer
Santosh Kesari 24
Testing effectiveness (Phase 2)Study completedNCT00219297
What this trial is testing

Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer

Who this might be right for
Brain MetastasisNon-small Cell Lung Cancer
Novartis Pharmaceuticals 50
Large-scale testing (Phase 3)UnknownNCT01782287
What this trial is testing

Proteome-based Immunotherapy of Lung Cancer Brain Metastases

Who this might be right for
Neoplasm Metastasis
NeuroVita Clinic 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07413952
What this trial is testing

Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases

Who this might be right for
NSCLC
The First Affiliated Hospital of Guangzhou Medical University 45
Not applicableStudy completedNCT03910556
What this trial is testing

Re-craniotomy and Complications After Elective Neurosurgery

Who this might be right for
Brain TumorBrain MetastasesBrain Cancer+1 more
Chiang Mai University 439
Testing effectiveness (Phase 2)Study completedNCT02595905
What this trial is testing

Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases

Who this might be right for
Metastatic BRCA Hereditary Breast CarcinomaMetastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+3 more
National Cancer Institute (NCI) 344
Next Page